Copenhagen, Denmark – Novo Holdings A/S, a leading global life sciences investor, today announces a significant investment in HPNow, a Danish firm pioneering an innovative form of water treatment, alongside the Export and Investment Fund of Denmark (EIFO) and existing investors MatiTech, Evonik Venture Capital and AP Ventures. Read more…
COPENHAGEN, DENMARK – September 14, 2023. With a total commitment of EUR 443 million (DKK 3.3 billion) from anchor investors Novo Holdings and PKA and several other investors, Glentra Capital (‘Glentra’) today announced the first close of its energy transition fund, Glentra Fund I. Based in Copenhagen and London, Glentra is a newly established investment firm with […]
Novo Holdings, a leading international life science investor, today announced it has participated in a $290 million (USD) strategic financing round of Sangon Biotech. Sangon is a leading provider of life science tools and services, enabling scientists across China to perform state-of-the-art research in hospitals, universities and commercial settings. Read more…
Novo Holdings today announced it has participated in the EUR 30 million Series A Financing of Bactolife. ATHOS led the round, with participation from the Bill & Melinda Gates Foundation, Novo Holdings and other existing investors. Bactolife is a Danish bioindustrial company developing proprietary Binding Proteins™, which strengthen the gut microbiome of humans and animals […]
YOUNG biotech companies need “patient investors” with “deep pockets” to weather today’s financial storms, the head of Novo Holdings Seed Investments has told the Optimum Perspectives podcast. In an in-depth interview, Søren Møller said fledgling firms should accept it might be some time before investor confidence returns to the sector – and they need to […]
